Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
about
Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer.Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapy.TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
P2860
Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Prognostication of soft tissue ...... OP2A, HER-2/neu, and survivin.
@en
Prognostication of soft tissue ...... OP2A, HER-2/neu, and survivin.
@nl
type
label
Prognostication of soft tissue ...... OP2A, HER-2/neu, and survivin.
@en
Prognostication of soft tissue ...... OP2A, HER-2/neu, and survivin.
@nl
prefLabel
Prognostication of soft tissue ...... OP2A, HER-2/neu, and survivin.
@en
Prognostication of soft tissue ...... OP2A, HER-2/neu, and survivin.
@nl
P2093
P2860
P50
P1476
Prognostication of soft tissue ...... OP2A, HER-2/neu, and survivin.
@en
P2093
Fábio de Oliveira Ferreira
Isabela Werneck da Cunha
José Humberto Fregnani
Kátia Cândido Carvalho
Louise De Brot
Luiz F L Reis
Nair Hideko Muto
Rafael Malagoli Rocha
Roberto Falzoni
Samuel Aguiar
P2860
P2888
P304
P356
10.1245/S10434-011-2184-3
P577
2011-12-28T00:00:00Z
P5875
P6179
1051273877